enVVeno Medical
NVNO
14 hedge funds and large institutions have $6.16M invested in enVVeno Medical in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
17% more capital invested
Capital invested by funds: $5.26M → $6.16M (+$901K)
0.33% more ownership
Funds ownership: 10.22% → 10.55% (+0.33%)
13% less funds holding
Funds holding: 16 → 14 (-2)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.32M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$169K |
| 3 |
BlackRock
New York
|
+$138K |
| 4 |
State Street
Boston,
Massachusetts
|
+$124K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$6.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$501K |
| 2 |
Millennium Management
New York
|
-$157K |
| 3 |
Jane Street
New York
|
-$145K |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$109K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$77K |
NVNO Hedge Fund Activity: Q2 2021 in Review
14 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q2 2021, worth a combined $6.16M — up 17% from $5.26M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NVNO and 2 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 3 added.
The largest buyer was Vanguard Group, adding an estimated $1.32M. The largest seller was AIGH Capital Management, cutting an estimated $501K.
- 14 institutional investors held enVVeno Medical (NVNO) as of Q2 2021, down from 16 in Q1 2021.
- Funds reported $6.16M of enVVeno Medical stock for Q2 2021, up 17% quarter-over-quarter.
- 2 funds opened new enVVeno Medical positions in Q2 2021 and 4 closed out, a net change of -2 holders.
- The largest enVVeno Medical buyer in Q2 2021 was Vanguard Group, an estimated $1.32M added.
- The largest enVVeno Medical seller in Q2 2021 was AIGH Capital Management, an estimated $501K sold.
Based on aggregated 13F filings for Q2 2021.